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Abstract
Background: Recent findings suggest that marital status affects survival in patients with different types of cancer. However,
its role in the survival of patients with pancreatic ductal adenocarcinoma is unknown. In this study, we investigated whether
there was an association between marital status and overall survival (OS) in patients with pancreatic ductal adenocarcinoma
(PDAC).
Methods: Adult patients diagnosed with PDAC between 1998 and 2003 with known marital statuses were identified from
the Surveillance, Epidemiology, and End Results registry of the National Cancer Institute. OS for these patients was plotted
using the Kaplan-Meier method. Comparative risks of mortality were evaluated by using univariate and multivariate-
adjusted Cox regression models.
Results: Using Kaplan-Meier analysis, we found that the median overall survival of patients was 4 months and 3 months
(p,0.001) for married and unmarried patients, respectively. Subgroup analysis on patients with cancer-directed surgery
showed that the median survival was 16 months and 13 months (P,0.0005) for married and unmarried groups, respectively.
Multivariate analysis adjusting for age, race, sex, stage, year of diagnosis, radiation therapy and cancer-directed surgery
showed that patients who were married at the time of diagnosis had a significantly decreased risk of death at both 2
months (15% risk reduction) and 3 years (13% risk reduction) post diagnosis.
Conclusions: Marital status is an independent prognostic factor of both perioperative and long-term survival in patients
with PDAC. This observation may suggest a suboptimally met psychosocial need among PDAC patients that is partially
fulfilled by the support system provided by marriage.
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Introduction
42,470 individuals were diagnosed with pancreatic cancer and
32,300 individuals died from it in 2009, as estimated by The
American Cancer Society [1]. Pancreatic cancer patients that have
been reported to the Surveillance, Epidemiology, and End Results
(SEER) database of the National Cancer Institute from 1996 to 2004
have an overall 5-year relative survival rate of 5%, making it the
deadliest type of cancer [2]. Patients with pancreatic cancer rarely
respond positively to treatment, thus making any pursuable avenue
that may increase survival in these patients of significant importance.
It is well known that patient and environmental factors influence
patient survival. It has been shown that a patient’s overall mental
state of well-being, including the desire to live and available social
support has a significant effect on both their short and long term
outcome. It has been shown that married persons receive better
social support, including practical support and financial resources,
decreasing the pressure of everyday stressors such as transporta-
tion, paperwork and household chores, so that the patient can
focus on treatment. Marriage may also influence behaviors such as
health screenings, diet, and exercise, all of which are factors that
promote health and have been shown to prolong life [3].
Understanding how marriage influences survival will shed light
on the importance of social support mechanisms in management
of various diseases, including cancers. Marital status has been
found to impact the survival of various types of cancer including
kidney, bladder, prostate, breast, and colon cancers [4]. However,
little is known about the relationship between marital status and
survival in patients with pancreatic ductal adenocarcinoma
(PDAC). An investigation into the relationship between marital
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status and the survival of patients with PDAC opens up a potential
mechanism that may be influencing the survival of patients with
the world’s deadliest cancer, allowing for the establishment of
more holistic approaches to PDAC treatment that may positively
influence patient mortality.
Materials and Methods
Ethics statement: This study has been reviewed by the UNMC
Office of Regulatory Affairs (ORA) and has been determined to
not be subject to review by the Institutional Review Board (IRB)
under HHS or FDA regulations for the protection of human
subjects.
Patients were identified from the SEER database (period 1988
to 2003) with age $18 years diagnosed with PDAC whose marital
status was also known at the time of diagnosis. Patients with
missing data on stage, external beam radiation therapy and
cancer-directed surgery were excluded. Also excluded were
patients who received non-external beam radiation therapy
(EBRT).
Data were analyzed using the SAS 9.2 statistical software (Cary,
NC, USA). Overall survival curves were generated using the
Kaplan-Meier method and comparative risks of mortality were
evaluated using univariate and multivariate Cox regression models
[5]. Factors including marital status, sex, race, age at diagnosis,
year of diagnosis, cancer-directed surgical status, EBRT status,
and tumor stage were evaluated. Evaluation of tumor grade was
excluded from this analysis since over half of the sample
population had unknown grade. The SEER database defines
cancer-directed surgery as partial or total pancreatectomy with or
without regional lymph node dissection, subtotal gastrectomy, and
duodenectomy, excluding incisional biopsy, exploratory surgery,
bypass, any stand-alone surgery ending in the suffix –otomy or –
ostomy, and any surgical procedures performed solely for
diagnostic, staging, or palliative purposes (SEER Program code
manual, 2009). Due to the fact that cancer-directed surgery is well
known to have a significant impact on survival in patients with
PDAC, multivariate analyses were repeated beyond the patient set
as a whole to evaluate if the various parameters found to affect
patient survival in PDAC patients remained significant prognostic
factors of survival in sub-populations of patients who either did or
did not undergo cancer-directed surgery. All parameters were
evaluated at two time-points: 2 months post-diagnosis and 3 years
post-diagnosis. The 2 month time point was chosen due to the fact
that cancer-directed surgery for pancreatic adenocarcinoma is
often performed within the first 6–10 weeks post-diagnosis and is
associated with high morbidity which can itself lead to early
mortality. As such, the 2 month time point, considered
Figure 1. Relative Survival of Patients Diagnosed with Pancre-
atic Ductal Adenocarcinoma using SEER 9 data from 1988–
2006. Survival of patients with pancreatic ductal adenocarcinoma (PC)
can be separated into two qualitative phases. The first phase occurs in
the initial 3 years post-PC diagnosis in which patient survival declines
steeply. After 3 years post-diagnosis, PC patient survival declines much
more slowly in what can be considered the second phase of the PC
survival curve. The nature of these phases allows for 3-year survival to
be considered a reasonable endpoint for evaluation of long-term PC
patient survival. Annual survival estimates were calculated using
monthly intervals.
doi:10.1371/journal.pone.0021052.g001
Table 1. Patient Characteristics.
No. of patients (%)
Unmarried Married
Characteristic (N=13794) (N=20761) P
Sex ,0.0001
Male 4792 (35) 12971 (62)
Female 9002 (67) 7790 (38)
Race ,0.0001
White 10756 (78) 17501 (84)
Black 2238 (16) 1638 (8)
Other 800 (6) 1622 (8)
Age
Median Age at Diagnosis 71 67 ,0.0001
18–60 y/o 2894 (21) 5291 (25)
60–74 y/o 5381 (39) 10126 (49)
.74 y/o 5519 (40) 5344 (27)
Year of Diagnosis 0.0384
2001–2003 4961 (36) 7224 (35)
1998–2000 2959 (21) 4413 (21)
1193–1997 3431 (25) 5237 (25)
1988–1992 2443 (18) 3887 (19)
Cancer Directed Surgery ,0.0001
None 12180 (88) 17557 (85)
Surgery 1614 (12) 3204 (15)
Radiation Therapy ,0.0001
None 11505 (83) 16067 (77)
EBRT 2289 (17) 4694 (23)
Stage 0.0007
Localized 1154 (8) 1507 (7)
Regional 4157 (30) 6369 (31)
Distant 8483 (61) 12885 (62)
EBRT indicates external beam radiation therapy; A race of Other indicates Asian,
or Asian-Pacific Islander.
doi:10.1371/journal.pone.0021052.t001
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perioperative, represents an important time point in patient
therapy as well as representing general short-term survival. The 3
year time point was chosen to represent long-term survival because
the 3 year mark represents the end of the steep decline in the
pancreatic adenocarcinoma survival curve, after which the slope of
patient survival flattens (Figure 1), thus making 3 year survival an
acceptable working definition of long-term survival in PDAC. For
analysis of both 2 month and 3 year survivals, data for all patients
with longer survival times were censored at the respective time
points.
Results
Patient characteristics
There were 72,727 cases of pancreatic adenocarcinoma
reported in the SEER database from 1973 to 2006. All cases in
which diagnoses were made before 1988 (17287) were excluded
because of incomplete information on staging and surgery. Cases
diagnosed from 2004 to 2006 (15385) were also excluded to allow
calculation of 3 year survival. We also removed cases with missing
information on marriage (1264), surgery (342), external beam
radiation therapy (EBRT) (729), stage (3157), and pediatric cases
(8), ending up with a final sample of 34,555 cases (married: 20761,
unmarried 13794).
Patient characteristics with different marital statuses are
described in Table 1. Patients who were married at the time of
diagnosis were more likely to be white, male and younger as
compared to their unmarried counterparts. Additionally, married
patients were more likely to have undergone cancer directed
surgery as well as EBRT.
Overall survival 3-years post diagnosis by marriage
As shown in Figure 2, we plotted Kaplan-Meier curves and used
the log-rank test to compare overall survival rate in the married
group with that in the unmarried group. The median survival and
3-year overall survival were 5 (95% CI: 4.9–5.1) months and 6%
respectively for the married group, compared with 4 (95% CI: 3–
4) months and 4% for the unmarried group (p,0.001). Upon
univariate analysis, factors that were associated with decreased 3-
year overall survival in PDAC patients included male sex, non-
Caucasian race, increased age at diagnosis, earlier year of
diagnosis, lack of cancer-directed surgery, lack of radiation
therapy, more advanced stage, and being unmarried. Multivariate
analysis using the Cox proportional harzard model was performed
to compare the married group with unmarried group after
controlling for all above mentioned covariates. The results are
reported in Table 2. Factors that continued to correlate with
decreased 3-year overall survival included being male, African
American race, increased age at diagnosis, earlier year of
diagnosis, lack of cancer-directed surgery, lack of radiation
therapy, higher stage, and being unmarried. Positive marital
status resulted in a 13% decrease in risk of death at 3 years post
diagnosis for patients with PDAC after adjusting for age, gender,
race, year of diagnosis, stage, cancer-directed surgery and EBRT.
Figure 2. Kaplan-Meier Survival Curves Comparing Patient Marital Status. A Kaplan-Meier survival curve comparing survival based on
marital status among all patients diagnosed with pancreatic ductal adenocarcinoma (PC) between 1998 and 2003 with known marital status shows
increased survival among married patients as compared to those who were non-married at the time of diagnosis. RED indicates patients who were
married at the time of diagnosis and BLUE represents patients who were not married at the time of diagnosis. Total patients for each patient group,
as well as total and censored patients at 12, 24, and 36 months are indicated. For each time point, ‘‘total’’ indicates the number of patients with ample
follow-up information to determine survival at the respective time point. ‘‘Censored’’ indicates the number of patients who lived beyond the
respective time point. This method of data representation was chosen rather than indicating at-risk patients for each time point to allow for easier
interpretation of overall survival at 12, 24, and 36 months. Total patient number indicated at 0 months is equivalent to total at-risk for each patient
group. For each time point, ‘‘at-risk’’ can be considered the number of ‘‘censored’’ patients from the previous time point minus the number of
patients lost to follow-up between the previous and current time points. Patients lost to follow-up between time points are indicated by the
respective decrease in ‘‘total’’ values.
doi:10.1371/journal.pone.0021052.g002
Marital Status and PDAC Survival
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Subgroup analysis were performed to determine the effect of
marriage on 3-year overall survival in patients with and without
cancer-directed surgery. Figures 3 and 4 show Kaplan-Meier
survival by marriage in patients without and with cancer-directed
surgery, respectively. For patients with cancer-directed surgery,
the median survival and 3-year overall survival were 16 (95% CI:
15–17) months and 25% respectively for the married group,
compared with 13 (95% CI: 12–14) months and 22% for the
unmarried group (p,0.0005). In contrast, for patients without
cancer-directed surgery, the median survival and 3-year survival
were 4 (95% CI: 3.9–4.1) months and 2% respectively for the
married group, compared with 3 (95% CI: 2.9–3.1) months and
1.8% for the unmarried group (p,0.0001). On multivariate
analysis of patients who did not undergo cancer-directed surgery,
positive marital status as well as female sex, non-African American
race, younger age at diagnosis, later year of diagnosis, radiation
therapy, and lower stage all remained positive predictors of
survival (Table 3). For patients who did undergo cancer-directed
surgery, the same positive predictors of 3-year overall survival exist
(Table 4).
Perioperative mortality by marriage
The perioperative mortalities at 2 months post diagnosis were
9.5% and 12% among married and unmarried groups respectively
(p,0.0005). Factors that correlated with decreased 2-month
overall survival on multivariate analysis included being male,
African American race, increased age at diagnosis, earlier year of
diagnosis, lack of cancer-directed surgery, lack of radiation
therapy, more advanced stage, and being unmarried (see
Table 5). Marriage yielded a 15% decrease in risk of death at
perioperative period.
Comparing the effect of marriage on 2-month and 3-year
survival
Interestingly, while positive marital status remained a predictor
for increased short-term and long-term survival in both patients
who underwent cancer-directed surgery and those who did not,
the amount by which it positively predicts survival is variable
between the two groups. As is illustrated in Figures 3 and 4, the
amount by which marital status predicts overall survival at 2
months in each of the two groups is very similar (15% for patients
without surgery vs. 16% for those with surgery), though increased
variability is present among patients who underwent cancer-
directed surgery as can be seen by the wider range of the 95% CI
(Tables 3 and 4). The ability of marital status to predict overall
survival 3 years post diagnosis, however, is greater in patients who
did not undergo cancer directed surgery, having a HR of 0.87 vs.
0.90 for patients with cancer-directed surgery. This difference may
reflect that the ability of marital status to predict long-term survival
is enhanced with more advanced stage disease which would
preclude cancer-directed surgery. Conversely, this finding may
also signal that, though marriage is a positive predictor of overall
survival, cancer-directed surgery may be such a significant
predictor of survival that its effects partially drown-out the
predictive ability of marital status.
Discussion
PDAC is the deadliest cancer in the world, with an overall 5-
year survival rate of 5% [2]. Currently, no current treatments
result in objective clinical response in more than 20% of patients
and no treatment regimen has been found that extends survival
beyond a few months [6]. Thus, all avenues that can be found to
increase survival in afflicted patients are of significant clinical
impact. This study is the first to epidemiologically link marital
status with survival in PDAC in the American population. While
traditional prognostic factors such as age, stage, tumor resection,
and tumor irradiation had greater impacts on patient survival, we
observed that patient marital status was a more significant
predictor of both short-term and long-term survival than patient
sex or race, two factors well established to correlate with post-
diagnostic life-span in PDAC. Additionally, marital status had a
greater impact on peri-operative survival than did a diagnosis of
regional tumor involvement versus localized disease. Such impact
of patient marital status was found to be independent of patient
surgical status as well, precluding any confounding impact that
may have resulted from such treatment.
Marriage is well known to have a positive impact on patient
survival across many malignancies though its effects, both in
quantity and quality, vary from study to study and between
Table 2. Univariate and Multivariate Analysis of Overall 3 year
Survival in Patients with Pancreatic Ductal Adenocarcinoma.
Univariate analysis Multivariate analysis
Variable HR (95%CI) P HR (95%CI) P
Marital Status
Unmarried 1.00 1.00
Married 0.83 (0.82–0.85) ,0.0001 0.87 (0.85–0.89) ,0.0001
Sex
Men 1.00 1.00
Women 0.97 (0.95–0.99) 0.0100 0.91 (0.89–0.94) ,0.0001
Race
White 1.00 1.00
Black 1.12 (1.08–1.16) ,0.0001 1.12 (1.08–1.16) ,0.0001
Other*? 1.00 (0.96–1.04) 0.8869 0.99 (0.94–1.03) 0.4988
Age at Diagnosis
,60 1.00 1.00
60–74 1.28 (1.25–1.32) ,0.0001 1.30 (1.26–1.34) ,0.0001
.74 1.67 (1.62–1.72) ,0.0001 1.63 (1.58–1.68) ,0.0001
Year of Diagnosis
2001–2003 1.00 1.00
1998–2000 1.05 (1.02–1.08) 0.0014 1.05 (1.02–1.08) 0.001
1993–1997 1.12 (1.09–1.15) ,0.0001 1.13 (1.10–1.16) ,0.0001
1988–1992 1.17 (1.12–1.20) ,0.0001 1.19 (1.15–1.22) ,0.0001
Cancer Directed
Surgery
None 1.00 1.00
Surgery 0.34 (0.32–0.35) ,0.0001 0.46 (0.4–0.48) ,0.0001
Radiation Therapy
None 1.00 1.00
EBRT 0.56 (0.54–0.57) ,0.0001 0.72 (0.70–0.74) ,0.0001
Stage
Localized 1.00 1.00
Regional 1.13 (1.08–1.18) ,0.0001 1.21 (1.16–1.27) ,0.0001
Distant 2.23 (2.13–2.33) ,0.0001 1.83 (1.75–1.91) ,0.0001
HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam
radiation therapy; A race of Other indicates Asian, or Asian-Pacific Islander.
*Variable shown to not be predictive of survival in univariate analysis.
?Variable shown to not be predictive of survival in multivariate analysis.
doi:10.1371/journal.pone.0021052.t002
Marital Status and PDAC Survival
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cancers. The impact of marriage on cancer survival has been
studied using both SEER as well as other country-specific cancer
databases. Currently the most comprehensive (with regard to
cancer type) study yet undertaken linking marital status with
cancer prognosis, and the only study to date including pancreatic
cancer in its analysis, looked at malignancies of the stomach,
colon/rectum, lung, breast, cervix, corpus uteri, ovary, prostate,
pancreas, and bladder as well as two hematologic malignancies
(multiple myeloma and leukemia) using combined data from the
Norwegian Cancer Registry and Norwegian Population Register
and Population Census from 1960, 1970 and 1980 [4]. This study
found that marriage increased 5-year relative survival by 15% in
cancer in general, with the greatest increase in survival observed in
males with malignant melanoma (Hazard Ratio (H.R.): 1.56,
p,0.05) and the least in leukemia and uterine cancer. In total,
marriage was found to be a statistically significant independent
predictor of survival in stomach (H.R.: 1.09–1.15), lung (H.R.:
1.13–1.23), and pancreatic cancers (H.R.: 1.03–1.32) among both
sexes as well as in females with breast (H.R.: 1.13), ovarian (H.R.:
1.49) and cervical cancers (H.R.: 1.28) and males with prostate
cancer (H.R.: 1.12), bladder cancer (H.R.: 1.49), and myeloma
(H.R.: 1.56) (p,0.05 for all) [4]. Similar to our results, this
Norwegian study found that marriage increases long-term survival
in pancreatic cancer by 3–32%, suggesting that our results are
consistent across multiple primarily-Caucasian populations.
In contrast, however, this Norwegian study did not analyze
short-term survival for any cancer, but did separate non-married
persons into individual groups based on being never-married,
divorced, or widowed as well as analyzing each sex individually.
Further, this study analyzed relative survival, not overall survival
and compared the survival advantage in cancer patients to that
conferred by marriage in the general population, preventing
erroneous conclusions from being drawn with regard to the
survival advantage of marriage in the specific context of
malignancy. Such analysis, however, is only considered necessary
upon analyses of non-aggressive cancers with long survival times
[4]. Another study was published in 2005 using SEER data to
analyze the affect of marital status on survival in women over 65
years of age diagnosed with breast cancer and found that marriage
increased 3-year overall-survival by 25% [7]. Interestingly, this
study merged the SEER survival, tumor, and treatment data with
Medicare data to analyze potential confounding effects of
sociodemographics and comorbidities, though neither was found
to substantially affect the positive association of marriage with
improved survival (though increased income was found to improve
the association). Further contrasting this study with ours is the fact
that only patients diagnosed between 1991 and 1995 were entered
into the analysis and, again, short-term survival was not analyzed
[7]. A third study, published just this year, showed that marriage
elicited improved 5-year survival in women diagnosed with
cervical cancer, however this survival advantage was lost when
corrected for tumor stage and cancer-directed radiation treatment,
Figure 3. Kaplan-Meier Survival Curves Comparing Patient Marital Status among patients who did not undergo cancer-directed
surgery. A Kaplan-Meier survival curve comparing survival based on marital status among all patients diagnosed with pancreatic ductal
adenocarcinoma (PC) between 1998 and 2003 with known marital status who did not undergo cancer-directed surgery. This comparison illustrates
that the increased survival among married patients as compared to those who were non-married at the time of diagnosis continues to be significant
regardless of if the patient was not surgically treated for his or her primary tumor. RED indicates patients who were married at the time of diagnosis
and BLUE represents patients who were not married at the time of diagnosis. Total patients for each patient group, as well as total and censored
patients at 12, 24, and 36 months are indicated. For each time point, ‘‘total’’ indicates the number of patients with ample follow-up information to
determine survival at the respective time point. ‘‘Censored’’ indicates the number of patients who lived beyond the respective time point. This
method of data representation was chosen rather than indicating at-risk patients for each time point to allow for easier interpretation of overall
survival at 12, 24, and 36 months. Total patient number indicated at 0 months is equivalent to total at-risk for each patient group. For each time point,
‘‘at-risk’’ can be considered the number of ‘‘censored’’ patients from the previous time point minus the number of patients lost to follow-up between
the previous and current time points. Patients lost to follow-up between time points are indicated by the respective decrease in ‘‘total’’ values.
doi:10.1371/journal.pone.0021052.g003
Marital Status and PDAC Survival
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suggesting that marriage itself may increase the likelihood of early
diagnosis and/or aggressive treatment of cervical cancer but does
not itself independently affect survival [8]. Like ours, this study was
conducted using the SEER database however, in contrast, only
patients diagnosed from 1992 to 1996 (7997 women in total) were
included in the study, non-married persons were further classified
into never-married, divorced/separated, and widowed groups, and
no short-term survival was analyzed. Beyond these studies directly
linking marriage to survival, it has also been found that an increase
in social support and self-efficacy, both being linked to marriage, is
strongly correlated with decreased rates of depression, distress, and
anxiety, all of which have been linked to increased morbidity and
mortality in cancer patients [9–14].
While the mechanism underlying the improved survival
associated with marriage in patients with PDAC is not entirely
clear, two potential reasons are proposed: those with psychiatric or
physical impairments may be less likely to marry, thereby causing
this observation to reflect a healthy selection bias, or marriage may
provide with it inherent benefits to health through the support
system it establishes [9]. Of note, these two potential mechanisms
for increased survival among the married are not mutually
exclusive but, for use in understanding and improving prognosis in
PDAC, only analysis of the latter is clinically practical. Multiple
mechanisms exist by which marriage itself may provide increased
survival in pancreatic cancer, most of which pertain to
psychosocial support through increased access to healthcare,
increased prominence of healthful lifestyles, or a decreased
quantity and quality of stressors. As an example, married persons
may enjoy greater financial resources than those who are
unmarried due to gains from economies of scale. Evidence for
this correlation between marriage and finances is widespread, has
been found throughout the world, and has the potential to allow
for decreased non-medically related stress due to a perceived
economic ‘‘safety-net’’ as well as increasing access to healthcare,
better food, and better housing [9]. Additionally, studies have
repeatedly shown that marriage may positively influence behaviors
such as undergoing health screenings, accessing appropriate
healthcare resources, improved diet, and routinely partaking in
exercise, all of which are factors that promote health and have
been shown to prolong life [9,10,15]. Evidence for the mechanism
behind this comes from a recent study, in which it was found that
degree of loneliness and perceived social support have the greatest
effect on increasing healthy behaviors. Marriage, too, may provide
for earlier detection of symptoms from both the primary disease as
well as life-threatening or life-shortening treatment toxicities,
allowing them to be addressed more rapidly and thus stemming
their effects before they can have a negative impact on survival
[10,15]. Married persons receive better social support as well,
giving them a greater sense of happiness and acceptance, often
referred to as self-efficacy [9,16]. This support helps prevent the
illness from encompassing the entire life of the patient, allowing
them to focus on something joyful and thereby giving the patient a
Figure 4. Kaplan-Meier Survival Curves Comparing Patient Marital Status among patients who underwent cancer-directed surgery.
A Kaplan-Meier survival curve comparing survival based on marital status among all patients diagnosed with pancreatic ductal adenocarcinoma (PC)
between 1998 and 2003 with known marital status who underwent cancer-directed surgery. This comparison illustrates that the pro-survival effects of
marriage hold true among patients who underwent tumor resection, a procedure that is considered the greatest prognostic factor among patients
diagnosed with pancreatic cancer. RED indicates patients who were married at the time of diagnosis and BLUE represents patients who were not
married at the time of diagnosis. Total patients for each patient group, as well as total and censored patients at 12, 24, and 36 months are indicated.
For each time point, ‘‘total’’ indicates the number of patients with ample follow-up information to determine survival at the respective time point.
‘‘Censored’’ indicates the number of patients who lived beyond the respective time point. This method of data representation was chosen rather than
indicating at-risk patients for each time point to allow for easier interpretation of overall survival at 12, 24, and 36 months. Total patient number
indicated at 0 months is equivalent to total at-risk for each patient group. For each time point, ‘‘at-risk’’ can be considered the number of ‘‘censored’’
patients from the previous time point minus the number of patients lost to follow-up between the previous and current time points. Patients lost to
follow-up between time points are indicated by the respective decrease in ‘‘total’’ values.
doi:10.1371/journal.pone.0021052.g004
Marital Status and PDAC Survival
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mental outlet associated with fundamental pleasure which may
translate to a more concrete desire to live. Further, this social
support often coincides with increased practical support such as
transportation, paperwork, assistance with activities of daily living,
and household chores; reducing day-to-day stress of the patient
and enabling them to fully focus on treatment. While this practical
support not only increases the ease with which patients can access
their physicians, medications, and treatment facilities, all of which
have obvious positive impacts on survival, the accomplishment of
reduction in stress and the anxiety that comes with it cannot be
overlooked. Indeed, none of these aspects of marriage affecting
survival must exist inside a vacuum, alone being responsible for
increasing survival in PDAC but rather all likely work in
conjunction to establish the global qualitative reality that marriage
provides a mental and physical safety net for those diagnosed with
deadly disease.
While this current study is both enlightening and relevant to
clinical practice, it is not without limitations. The lack of detailed
patient information, such as patient financial status, the existence
of preexisting conditions, and mental health, prevent a subset of
potential confounders from being accounted for in our analysis as
well as disallowing the ability to propose specific mechanisms by
which marriage offers increased survival in PDAC. Additionally,
the lack of relevant aspects of patient history prevents the
deciphering of whether the positive correlation between marital
status and PDAC survival is due to inherent benefits from
marriage or is simply a reflection of a healthy selection bias found
in married patients. The insufficient inclusion of tumor grade in
SEER PDAC patient data also precludes any analysis of tumor
morphology as a potential confounder. Further, due to the absence
of information on chemotherapy included in the SEER database,
its effect on survival could not be evaluated. This analysis also did
not separate non-married patients based on being never-married,
divorced, or widowed, did not analyze each sex individually, did
not take into account cohabitation, and did not account for length
of time each patient had been married/non-married at the time of
diagnosis. Importantly, as pancreatic cancer-specific survival data
is not available in the SEER database, the impact of marital status
on pancreatic cancer mortality due to non-cancer related events
Table 3. Multivariate Analysis of Marital Status on Overall 2
Month and 3 year Survival in Patients with Pancreatic Ductal
Adenocarcinoma Without Cancer-Directed Surgery.
2 Month Survival 3 Year Survival
Variable HR (95%CI) P HR (95%CI) P
Marital Status
Unmarried 1.00 1.00
Married 0.85 (0.83–0.87) ,0.0001 0.87 (0.85–0.89) ,0.0001
Sex
Men 1.00 1.00
Women 0.90 (0.87–0.92) ,0.0001 0.91 (0.89–0.94) ,0.0001
Race
White 1.00 1.00
Black 1.12 (1.08–1.16) ,0.0001 1.11 (1.07–1.15) ,0.0001
Other*? 0.99 (0.94–1.04) 0.6529 0.98 (0.94–1.03) 0.3772
Age at Diagnosis
,60 1.00 1.00
60–74 1.27 (1.23–1.32) ,0.0001 1.27 (1.23–1.31) ,0.0001
.74 1.62 (1.57–1.68) ,0.0001 1.59 (1.54–1.64) ,0.0001
Year of Diagnosis
2001–2003 1.00 1.00
1998–2000 1.05 (1.01–1.08) 0.0116 1.04 (1.00–1.07) 0.0299
1993–1997 1.14 (1.12–1.18) ,0.0001 1.12 (1.08–1.15) ,0.0001
1988–1992 1.21 (1.17–1.26) ,0.0001 1.18 (1.14–1.22) ,0.0001
Radiation Therapy
None 1.00 1.00
EBRT 0.60 (0.58–0.62) ,0.0001 0.69 (0.67–0.71) ,0.0001
Stage
Localized 1.00 1.00
Regional* 1.02 (0.96–1.09) 0.4521 1.08 (1.02–1.13) 0.0065
Distant 1.74 (1.65–1.84) ,0.0001 1.66 (1.58–1.74) ,0.0001
HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam
radiation therapy; A race of Other indicates Asian, or Asian-Pacific Islander.
*Variable shown to not be predictive of 2 month survival.
?Variable shown to not be predictive of 3 year survival.
doi:10.1371/journal.pone.0021052.t003
Table 4. Multivariate Analysis of Marital Status on Overall 2
Month and 3 year Survival in Patients with Pancreatic Ductal
Adenocarcinoma With Cancer-Directed Surgery.
2 Month Survival 3 Year Survival
Variable HR (95%CI) P HR (95%CI) P
Marital Status
Unmarried 1.00 1.00
Married 0.84 (0.77–0.93) 0.0005 0.90 (0.84–0.97) 0.0047
Sex
Men 1.00 1.00
Women 0.86 (0.79–0.95) 0.0015 0.92 (0.86–0.99) 0.0204
Race
White 1.00 1.00
Black 1.27 (1.10–1.46) 0.0012 1.21 (1.09–1.36) 0.0006
Other? 1.26 (1.06–1.49) 0.0088 1.08 (0.95–1.24) 0.2256
Age at Diagnosis
,60 1.00 1.00
60–74 1.63 (1.46–1.82) ,0.0001 1.44 (1.33–1.56) ,0.0001
.74 2.06 (1.81–2.35) ,0.0001 1.81 (1.64–1.99) ,0.0001
Year of Diagnosis
2001–2003 1.00 1.00
1998–2000 1.14 (1.01–1.29) 0.03 1.16 (1.06–1.27) 0.0009
1993–1997 1.30 (1.16–1.46) ,0.0001 1.25 (1.15–1.36) ,0.0001
1988–1992 1.35 (1.19–1.54) ,0.0001 1.30 (1.17–1.43) ,0.0001
Radiation Therapy
None 1.00 1.00
EBRT 0.52 (0.47–0.58) ,0.0001 0.85 (0.79–0.91) ,0.0001
Stage
Localized 1.00 1.00
Regional 1.94 (1.67–2.25) ,0.0001 1.77 (1.60–1.96) ,0.0001
Distant 2.91 (2.44–3.46 ,0.0001 2.21 (1.95–2.51) ,0.0001
HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam
radiation therapy; A race of Other indicates Asian, or Asian-Pacific Islander.
?Variable shown to not be predictive of 3 year survival.
doi:10.1371/journal.pone.0021052.t004
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also could not be assessed. While this study remains the first of its
kind analyzing the effects of marital status on survival in PDAC in
the American population, each of these limitations much be
addressed in future studies to fully decipher what affect marriage
truly has on PDAC prognosis.
This investigation of the relationship between marital status and
PDAC survival opens up a potential mechanism that may be
influencing the survival of patients with the world’s deadliest
cancer. Discovery of the true cause(s) underlying the ability of
marriage to increase survival in pancreatic cancer is necessary.
Once these mechanisms are deciphered, the clinical challenge will
be to incorporate prognostically beneficial aspects of marriage into
the treatment of all patients diagnosed with PDAC, allowing for
the establishment of more holistic approaches which may
positively influence patient morbidity and mortality. In this way,
the positive impact on survival provided by marriage can be
enjoyed by all PDAC patients, regardless of marital status.
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